期刊文献+

乳腺癌上皮-间质转化后引发BCRP介导的多药耐药的研究 被引量:15

Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein
下载PDF
导出
摘要 背景与目的:研究发现肿瘤的侵袭浸润和转移增强是上皮-间质转化(epithelial mesenchymal transition,EMT)所致,而EMT的发生也与肿瘤细胞多药耐药现象的发生密切相关。本研究通过分析乳腺癌组织和细胞中EMT与乳腺癌耐药蛋白表达的相关性,探讨EMT对乳腺癌中乳腺癌耐药蛋白(breast cancer resistant protein,BCRP)介导多药耐药的影响。方法:免疫组织化学方法检测乳腺癌组织中Snail、BCRP的表达;构建Snail真核表达载体pCDNA3.1-Snail,转染至MCF-7细胞,采用免疫荧光、Westernblot、Real-timePCR检测转录抑制因子snail、上皮标志物E-钙粘素、间质标志物vimentin以及多药耐药蛋白BCRP的表达;MTT法检测细胞对米托蒽醌的耐药指数。结果:免疫组化结果显示乳腺癌组织中Snail、BCRP的表达呈显著相关;免疫荧光、Westernblot、Real-timePCR显示与亲本MCF-7细胞相比,转染Snail后的MCF-7细胞中E-cadherin表达水平明显降低,而snail、vimentin和BCRP的表达水平明显增加;MTT结果显示细胞对米托蒽醌的耐药指数增加至9.93。结论:转染snail真核表达载体pCDNA3.1-snail可使乳腺癌MCF-7细胞发生EMT,并导致细胞中BCRP表达增加,引发BCRP介导的多药耐药。 Background and Objective: Epithelial-mesenchymal transition (EMT) not only initiates invasion and metastasis of tumors, but also induces multidrug resistance in tumor cells. Our experiment analyzed the dependability between breast cancer resistant protein (BCRP) and EMT in breast cancer to explore the effect of EMT on BCRP-mediated multidrug resistance. Methods: The expressions of BCRP and transcription inhibitor Snail (Snail) in breast cancer were detected by immunohistochemistry. The eukaryotic expression vector pCDNA3.1-Snail was constructed and then transfected into human breast cancer cell line MCF-7. Snail, epithelial marker gene E-cadherin, interstitial marker gene Vimentin, multidrug resistance protein BCRP, and relative drug resistance were measured by immunofluorescence, Western blot, real-time polymerase chain reaction (PCR), and MTT assay. Results:Immunohistochemistry showed that Snail was highly correlated with BCRP in breast cancer. Immunofiuorescence, Western blot, and real-time PCR revealed that compared with parent cell MCF-7, after transfected with Snail, the expression of E-cadherin in MCF-7 decreased, but Snail, Vimentin, and BCRP increased. MTT displayed that the relative drug resistance increased to 9.93. Conclusion. After transfected with eukaryotic expression vector pCDNA3.1- Snail, breast cancer cells MCF-7 showed EMT with BCRP-mediated multidrug resistance.
出处 《癌症》 SCIE CAS CSCD 北大核心 2010年第2期159-165,共7页 Chinese Journal of Cancer
基金 山东省自然科学基金项目(No.Y2008C75)~~
关键词 乳腺肿瘤 多药耐药 上皮-间质转化 Breast cancer, multidrug resistance, EMT
  • 相关文献

参考文献3

二级参考文献31

  • 1Mariana Ferreira Leal,Eleonidas Moura Lima,Patrícia Natália Oliveira Silva,Paulo Pimentel Assumpo,Danielle Queiroz Calcagno,Spencer Luiz Marques Payo,Rommel Rodríguez Burbano,Marília de Arruda Cardoso Smith.Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil[J].World Journal of Gastroenterology,2007,13(18):2568-2574. 被引量:24
  • 2Schierling W, Kunz-Schughart LA, Muders F, et al. Fates of genetically engineered haematopoietic and mesenchymal stem cell grafts in normal and injured rat hearts. J Tissue Eng Regen Med, 2008, 11: 354-364.
  • 3Zhao F, Zhang YF, Liu YG, et al. Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc, 2008, 40: 1700-1705.
  • 4Hill WD, Hess DC, Martin SA, et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol, 2004, 63: 84-96.
  • 5Isabelle P, Martine SK, Arnon N, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol, 2002,3: 687-694.
  • 6Ma W, Cai S, Du J, et al. SDF-1/54-DCN: a novel recombinant chimera with dual inhibitory effects on proliferation and chemotaxis of tumor cells. Biol Pharm Bull, 2008, 31: 1086-1091.
  • 7Kollmar O, Rupertus K, Scheuer C, et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia, 2007, 9: 862-870.
  • 8Koizumi K, Hojo S, Akashi T, et al. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci, 2007, 98: 1652-1658.
  • 9Park SH, Cheung LW, Wong AS, et al. Estrogen regulates snail and slug in the downregulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol, 2008, 22 :2085-2098.
  • 10Zhang A, Chen G, Meng L, et al. Antisense-Snail transfer inhibits tumor metastasis by inducing E-cadherin expression. Anticancer Res, 2008, 28: 621-628.

共引文献15

同被引文献150

  • 1钟丽,安云婷,喻金梅.卵巢上皮性癌组织中miR-145与PI3K/AKT信号通路相关性的研究[J].江西医药,2013,48(5):388-391. 被引量:3
  • 2赵晓利,李力,郭建新,徐德斌,胡珊,陈竹钦.顺铂诱导survivin表达改变与宫颈癌细胞化疗敏感性的关系[J].第三军医大学学报,2005,27(10):1023-1025. 被引量:6
  • 3韩为东,孟元光,廖代祥,李琦,伍志强,司艺玲,郝好杰,母义明,赵亚力.LRP16通过调控E-钙黏着蛋白的表达促进MCF-7细胞的侵袭生长[J].中国生物化学与分子生物学报,2006,22(9):724-732. 被引量:17
  • 4吴氢凯,罗来敏,吴洪军,陶雯琪,陆洪芬,施达仁,冯洁.BRCA1蛋白在原发性上皮性卵巢癌中的表达[J].上海交通大学学报(医学版),2006,26(12):1326-1330. 被引量:2
  • 5Korpal M,Lee ES,Ha G,et al.The miR-200 family inhibits epithelial-mescnchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEBI and ZEB2[J].J Biol Chem,2008,283 (22):14910-14914.
  • 6Christiansen JJ,Rajasekaran AK.Reassessing epithelial to mescnchymal transition as a prerequisite for carcinoma invasion and metastasis[J].Cancer Res,2006,66(17):8319 -8326.
  • 7Robson EJ,Khaled WT,Abell K,et al.Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines[J].Differentiation,2006,74 (5):254-264.
  • 8Del Castillo G,Murillo MM,Alvarez-Bacrientes A,et al.Autoerine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes:Role of EGF receptor ligands[J].Exp Cell Res,2006,312 (15):2860-2871.
  • 9Meyer zu Schwabedissen HE,Grube M,Dreisbach A,et al.Epidermal growth facter-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP)[J].Drug Metab Dispes,2006,34(4):524-533.
  • 10Jechlinger M,Grunert S,Tamir IH,et al.Expression profiling of epithelial plasticity in tumor progression[J].Oncogene,2003,22 (46):7155 -7169.

引证文献15

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部